TCL Archive Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language September 18, 2009
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies. July 9, 2010
